Загрузка...
Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2
Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Taylor & Francis Group
2021-01-01
|
Серии: | mAbs |
Предметы: | |
Online-ссылка: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|